Story

After working many years for big cooperations and smaller biotech the owner and founder of the company realized that many smaller biotech companies struggle with simple questions due to lack of clinical development experience and leadership in drug development. Her passion is bringing novel therapies to patients with unmet medical needs. The agility and speed in smaller biotech environments to deliver this ambitious goal is often lacking the necessary medical expertise.

Over the years the owner and founder worked in different regions of the world including Europe, US and APAC including China and gained invaluable experience over a wide variety of different regional and local . Her passion remains in APAC and she is dedicated in supporting biotech companies in the cell and gene therapy field to achieving their goals.

"It has always been my dream to support smaller companies in underserved locations achieving their ambitious goal bringing novel therapies to patients" Dr. Martina Sersch, MD, owner and founder of Titronbio TM emphasized in a recent interview." In countries like China, where many talented researchers invent novel therapies providing long standing expertise can be an invaluable asset to leap frog them into the next level." As she has recently done with Gracellbio - a chinese local biotech with a successful IPO in 2021. We were all very proud of the achievement and hopefully many more can follow.